Suppr超能文献

使用Sensititre Yeast One对丝状真菌进行体外抗真菌药敏试验。

In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.

作者信息

Carrillo-Muñoz A J, Quindós G, Ruesga M, del Valle O, Pemán J, Cantón E, Hernández-Molina J M, Santos P

机构信息

Department of Microbiology, ACIA, Barcelona, Spain.

出版信息

Mycoses. 2006 Jul;49(4):293-7. doi: 10.1111/j.1439-0507.2006.01250.x.

Abstract

Sensititre is a colorimetric microdilution method for in vitro antifungal susceptibility testing based on the M27-A document (National Committee for Clinical Laboratory Standards) for yeasts. Difference between both methods is the presence of Alamar-blue and RPMI 1640 (glucose 2%) as culture medium. Antifungal susceptibility to amphotericin B, fluconazole, itraconazole, ketoconazole and flucytosine, 100 opportunistic filamentous fungi (Aspergillus spp., Fusarium spp., Scedosporium spp.) obtained from pathological samples was determined by the Sensititre method. Induction to conidium and sporangiospore formation at 35 degrees C was used to get inoculum and plates were covered by 1 ml of saline and suspensions were made by gently probing by a sterile loop. Optical densities of the conidial suspensions were adjusted to 80-82% transmittance for Aspergillus spp. and 68-70% for the rest of strains tested. Final inoculum concentration size was 0.4 x 10(4)-5 x 10(4) CFU ml(-1). Readings were made at 72 h of incubation at 35 degrees C; amphotericin B and itraconazole was active against Aspergillus fumigatus with CMI90 1 and 0.5 microg ml(-1), respectively, opposite to Scedosporium prolificans and Scedosporium apiospermum. As it was expected, a CMI90 of 256 microg ml(-1) for fluconazole and CMI90 for flucytosine amounting to 64 g ml(-1) were obtained. Sensititre Yeast One is a useful method and an alternative to reference methods to determine antifungal susceptibility of filamentous fungi for clinical laboratory routine. Correlation with microdilution results is studied. New triazole derivatives should be included as soon as their clinical use will be feasible.

摘要

Sensititre是一种基于用于酵母菌的M27 - A文件(美国国家临床实验室标准委员会)的比色微量稀释法,用于体外抗真菌药敏试验。两种方法的区别在于是否存在阿拉玛蓝以及使用RPMI 1640(2%葡萄糖)作为培养基。采用Sensititre方法测定了从病理样本中分离得到的100株机会性丝状真菌(曲霉属、镰刀菌属、足放线病菌属)对两性霉素B、氟康唑、伊曲康唑、酮康唑和氟胞嘧啶的抗真菌药敏情况。在35℃诱导分生孢子和孢子囊孢子形成以获得接种物,平板用1 ml盐水覆盖,并用无菌接种环轻轻搅动制成悬液。将曲霉属分生孢子悬液的光密度调整为透光率80 - 82%,其余受试菌株调整为68 - 70%。最终接种物浓度为0.4×10⁴ - 5×10⁴ CFU/ml⁻¹。在35℃孵育72小时后读数;两性霉素B和伊曲康唑分别对烟曲霉有活性,其90%最小抑菌浓度(CMI90)为1和0.5 μg/ml,而对多育足放线病菌和尖端足放线病菌则相反。正如预期的那样,氟康唑的CMI90为256 μg/ml,氟胞嘧啶的CMI90为64 μg/ml。Sensititre Yeast One是一种有用的方法,可替代参考方法用于临床实验室常规检测丝状真菌的抗真菌药敏情况。研究了其与微量稀释结果的相关性。一旦新的三唑衍生物临床可用,应尽快将其纳入检测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验